Lupin Aims To Be In The First Wave Of GLP-1s In Emerging Markets

Also, Discusses Upcoming US Injectables Launches And Its Position In Biosimilars Race

 
• By Urtė Fultinavičiūtė
  
Businessman surfing on waves as upward arrow.
(Shutterstock)

More from Earnings

More from Generics Bulletin